Blood content of asymmetric dimethylarginine: new insights into its dysregulation in renal disease. - Wikidata - awgldk - TriplyDB

Blood content of asymmetric dimethylarginine: new insights into its dysregulation in renal disease.

Blood content of asymmetric dimethylarginine: new insights into its dysregulation in renal disease.

http://www.wikidata.org/entity/Q37324434

about

Packed red blood cells are an abundant and proximate potential source of nitric oxide synthase inhibition Mechanisms of endothelial dysfunction in resistance arteries from patients with end-stage renal disease Correlation research on ADMA plasma levels and left ventricular function of peritoneal dialysis patients Established and theoretical factors to consider in assessing the red cell storage lesion Organic nitrates favor regression of left ventricular hypertrophy in hypertensive patients on chronic peritoneal dialysis.The role of asymmetric and symmetric dimethylarginines in renal disease.SDMA is an early marker of change in GFR after living-related kidney donation.Role of the human erythrocyte in generation and storage of asymmetric dimethylarginine.Unilateral nephrectomy causes an abrupt increase in inflammatory mediators and a simultaneous decrease in plasma ADMA: a study in living kidney donors.Association of the -449GC and -1151AC polymorphisms in the DDAH2 gene with asymmetric dimethylarginine and erythropoietin resistance in Chinese patients on maintenance hemodialysis.

P2860

Q28544807-F5E8D32E-16F8-4729-B2E5-57D2F57F1B9E Q28730306-BACDC613-074A-4A65-9902-9CD9B42F3CE4 Q34770081-99A300A5-56C1-49B2-99C7-B2CA8BA2B39C Q35252618-473CC1AB-DE65-4F98-A96F-EBF33D35B3CA Q36590001-5F26E9E6-F00F-4280-8D04-D1F175B5B3D6 Q37858880-9FEE61F2-40C0-4B81-8E36-1BCD8C90D36D Q39858329-E8F31F83-72EE-4969-91A4-769F027BA670 Q42502690-3AF647E6-8245-484B-AA47-779B654742CE Q43590526-C64FB7AD-C0A7-4E4E-AA07-1E8FDB414BE6 Q48313657-78AD7AEA-2B43-403E-A44C-A09940F3F785

P2860

Blood content of asymmetric dimethylarginine: new insights into its dysregulation in renal disease.

http://www.wikidata.org/entity/Q37324434

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 15 September 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Blood content of asymmetric di ...... ysregulation in renal disease.

@en

Blood content of asymmetric di ...... ysregulation in renal disease.

@nl

type

label

Blood content of asymmetric di ...... ysregulation in renal disease.

@en

Blood content of asymmetric di ...... ysregulation in renal disease.

@nl

prefLabel

Blood content of asymmetric di ...... ysregulation in renal disease.

@en

Blood content of asymmetric di ...... ysregulation in renal disease.

@nl

P1433

Q37324434-559624DE-B603-4027-B515-65ECCBD703C9

P1476

Q37324434-F2953465-D940-4F4F-AA49-B745B2F73D6E

P2093

Q37324434-06044C6C-49AC-4467-8233-BBFBBDCA3CBE

Q37324434-1CF3E8FD-AAAC-4267-BEC6-769E10FF127F

Q37324434-638FB60C-893B-4620-BA8A-F21A641FC7F6

Q37324434-65B1C0DB-4885-4493-B1F1-0301EFC9A493

Q37324434-AC5D9C18-33CD-4566-9F95-A1641A0D9473

Q37324434-B27AB69F-A271-4700-9FD5-F82B1579FAA6

Q37324434-EBBAA80A-FAAE-4049-BAFC-BEFCBDCBF357

P2860

Q37324434-044332FB-5AC2-419C-89BA-0C4955F221CA

Q37324434-05D65F80-424C-4BCD-BB3F-D99E50EC3BFB

Q37324434-13BB2E42-DC3D-475F-8A0C-D8E86BBAD9B5

Q37324434-15A82913-DECC-4FCA-AC61-0380C18EECA9

Q37324434-173CE672-F172-47E8-80AB-47009A4E035F

Q37324434-38134689-61B4-47B2-A9DB-AE4D549D899C

Q37324434-3D3A3137-9B90-4C1C-9CB9-BC522A8B303A

Q37324434-4001F6D9-61C4-4391-A1A3-AC5DC2DF81B2

Q37324434-44D3B714-CA80-4420-99E8-560F840A6E5F

Q37324434-46195769-B9AD-4F42-8DCC-D0FF68644A4C

P304

Q37324434-2281B1A9-FF23-49AC-9167-27985270AFB4

P31

Q37324434-8FD58776-4D24-4626-9AF6-506CDCA6127C

P356

Q37324434-5281C704-FC3A-4B66-B5DC-236E3526D1D5

P407

Q37324434-098DD441-35E1-4150-A3DF-61951FCB4EA8

P433

Q37324434-33934E17-DA63-4C46-AA0B-8DAA18741E01

P478

Q37324434-B21A4752-2DB1-4288-9E6B-4E5E590EA23B

P577

Q37324434-855A05CD-B3CE-40F2-AE71-764B5C9449A1

P5875

Q37324434-30F0EA9D-F3E4-4515-ADB7-0963E8114E9E

P698

Q37324434-4A1D66E0-3937-4FEE-B3CC-5A345444C357

P932

Q37324434-4EAD813B-50C1-48EA-A859-008AF8E55A21

P356

P1433

Nephrology Dialysis Transplantation

P1476

Blood content of asymmetric di ...... ysregulation in renal disease.

@en

P2093

Crystal A Gadegbeku

http://www.w3.org/2001/XMLSchema#string

Kenneth A Jamerson

http://www.w3.org/2001/XMLSchema#string

Louis G D'Alecy

http://www.w3.org/2001/XMLSchema#string

Rachel L Perlman

http://www.w3.org/2001/XMLSchema#string

Raylene Platel

http://www.w3.org/2001/XMLSchema#string

Scott S Billecke

http://www.w3.org/2001/XMLSchema#string

Steven E Whitesall

http://www.w3.org/2001/XMLSchema#string

P2860

Aspirin protected against endothelial damage induced by LDL: role of endogenous NO synthase inhibitors in rats

Decrease of 3-methylhistidine and increase of NG,NG-dimethylarginine in the urine of patients with muscular dystrophy

Impaired endothelium-dependent vasodilatation in renal failure in humans.

Relationship of asymmetric dimethylarginine to dialysis treatment and atherosclerotic disease.

Abnormalities in L-arginine transport and nitric oxide biosynthesis in chronic renal and heart failure.

Symmetric dimethylarginine (SDMA) as endogenous marker of renal function--a meta-analysis.

Purification and properties of a new enzyme, NG,NG-dimethylarginine dimethylaminohydrolase, from rat kidney.

Inflammation and atherosclerosis in end-stage renal disease.

Endothelium-dependent vasodilation and oxidative stress in chronic renal failure: impact on cardiovascular disease.

Serum concentrations of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in patients with chronic kidney diseases.

P304

489-496

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NDT/GFN500

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2008-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23260891

http://www.w3.org/2001/XMLSchema#string

P698

18796436

http://www.w3.org/2001/XMLSchema#string

P932

2734175

http://www.w3.org/2001/XMLSchema#string